Adicet bio announces formation of scientific advisory board

Menlo park, calif and boston, july 15, 2021 (globe newswire) -- adicet bio, inc. (nasdaq: acet), a biotechnology company discovering and developing allogeneic gamma delta t cell therapies for cancer and other diseases, today announced the formation of a scientific advisory board (sab). the sab is comprised of renowned scientific leaders in the fields of t cell biology, immunology, and oncology.
ACET Ratings Summary
ACET Quant Ranking